Clin2
NCT06523465Possibly a fitRecruiting

Statin plus amlodipine for primary aldosteronism

Primary AldosteronismStatinMineralocorticoid Receptor AntagonistHypertension

Part of Heart & circulation, Hormones & metabolism clinical trials.

This trial tests whether combining a statin (usually for cholesterol) with amlodipine (a blood pressure medication) can better treat primary aldosteronism, a hormonal condition that causes high blood pressure. If you have this condition, this study may offer a new way to manage it.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
180 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You must have primary aldosteronism (a condition that makes too much of the hormone aldosterone, raising your blood pressure).
  • You cannot be allergic to amlodipine or any statin medicine (like atorvastatin or simvastatin).
  • You must not be pregnant or breastfeeding.
  • You should not have severe liver or kidney problems.
  • You should not have a serious mental illness.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04409431Recruiting
Spironolactone plus adrenal nerve treatment for adrenal overactivity

This trial studies whether blocking part of the adrenal blood supply (“adrenal artery ablation”) along with spironolactone can improve hormone-driven high blood pressure caused by primary aldosteronism. It may help people who have confirmed adrenal overactivity and do not want surgery.

Chongqing, Chongqing Municipality
NCT07137364Recruiting
Testing spironolactone with blood pressure drugs for PA

This trial looks at whether adding spironolactone to your current blood pressure medicines works better for people with primary aldosteronism (a condition where your adrenal glands make too much aldosterone, raising blood pressure). You may qualify if you have this form of high blood pressure but have declined surgery or don't have an adenoma.

Chongqing, Chongqing Municipality
NCT07470983Recruiting· Phase 2
Study of HRS-1780 for Primary Aldosteronism

This trial tests a new drug called HRS-1780 for people with primary aldosteronism, a condition that causes high blood pressure. The goal is to see if the drug is safe and effective in lowering blood pressure and managing the condition.

Chongqing, Chongqing Municipality
NCT03224312Recruiting
Study of primary aldosteronism in people with high blood pressure

This trial studies people with high blood pressure caused by a hormone problem called primary aldosteronism. If you qualify, the study may help doctors learn better ways to identify and manage this specific cause of blood pressure elevation.

Chongqing, Chongqing Municipality
NCT06941116Recruiting
Steroid test to screen for a common cause of high blood pressure

This trial tests whether a simple steroid-based test can help identify a specific type of high blood pressure called primary aldosteronism. If you have high blood pressure that needs medication, this study may help find a treatable cause.

Chongqing, Chongqing Municipality
NCT06457074Recruiting· Phase 4
Finerenone for primary aldosteronism (FAIRY trial)

This trial tests a drug called finerenone for people with a specific cause of high blood pressure (primary aldosteronism). It aims to see if finerenone can help lower blood pressure and improve hormone levels better than current care.

Chongqing, Chongqing Municipality

Hear when a new Primary Aldosteronism trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.